Valerie Morisset
CIK 1868517 · EVP, R&D AND CSO · last filed 2024-07-23
Valerie Morisset is an EVP, R&D AND CSO who has filed 12 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing shows the insider sold $988.5K of ELYM on Jul 23, 2024. Across all open-market trades the lifetime net is −$3.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
12
-$3.45M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Climb Bio, Inc. (ELYM) Delisted | EVP, R&D AND CSO | 61,317 | $5.11 | $313.3K | -$3.45M | 12 | 2024-07-23 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-23 | Climb Bio, Inc. (ELYM) Delisted | Sell (S) | −129,206 | -$988.5K | EDGAR |
| 2024-07-19 | Climb Bio, Inc. (ELYM) Delisted | Sell (S) | −41,783 | -$289.5K | EDGAR |
| 2024-07-17 | Climb Bio, Inc. (ELYM) Delisted | Sell (S) | −50,000 | -$356.5K | EDGAR |
| 2024-07-16 | Climb Bio, Inc. (ELYM) Delisted | Sell (S) | −92,377 | -$650.6K | EDGAR |
| 2024-07-11 | Climb Bio, Inc. (ELYM) Delisted | Sell (S) | −105,931 | -$736.5K | EDGAR |
| 2024-07-09 | Climb Bio, Inc. (ELYM) Delisted | Sell (S) | −12,342 | -$87.1K | EDGAR |
| 2024-07-03 | Climb Bio, Inc. (ELYM) Delisted | Mixed | −42,351 | -$338.0K | EDGAR |
| 2024-04-08 | Climb Bio, Inc. (ELYM) Delisted | Exer (M) | +17,847 | $4 | EDGAR |
| 2024-03-04 | Climb Bio, Inc. (ELYM) Delisted | Exer (M) | +20,728 | $14 | EDGAR |
| 2023-03-14 | Climb Bio, Inc. (ELYM) Delisted | Exer (M) | +316,410 | $523 | EDGAR |